Osteoboost Health Inc. just announced its sixth U.S. patent for its wearable device that uses vibration therapy to strengthen bones and help women live stronger, longer lives.

The company is tackling acritical health challenge: osteopenia, a condition affecting millions of women worldwide.

Osteoboost is the first and only FDA-cleared, non-drug prescription treatment for low bone density. Powered by NASA-inspired technology, the wearable belt targets high-risk areas like the lumbar spine and hips, using a proprietary vibration frequency to stimulate bone growth effectively.

Osteoboost’s clinical trials show up to 85% reduction in spine bone density loss and 55% reduction in hip bone density loss.

We have a conversation with CEO Laura Yecies, who  ...